Cargando…

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants

PURPOSE: To improve breast cancer risk stratification to enable more targeted early detection/prevention strategies that will better balance risks and benefits of population screening programmes. METHODS: 9362 of 57,902 women in the Predicting-Risk-Of-Cancer-At-Screening (PROCAS) study who were unaf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evans, D. Gareth R., Harkness, Elaine F., Brentnall, Adam R., van Veen, Elke M., Astley, Susan M., Byers, Helen, Sampson, Sarah, Southworth, Jake, Stavrinos, Paula, Howell, Sacha J., Maxwell, Anthony J., Howell, Anthony, Newman, William G., Cuzick, Jack
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548748/ https://www.ncbi.nlm.nih.gov/pubmed/30941651 http://dx.doi.org/10.1007/s10549-019-05210-2

Ejemplares similares

A case–control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density
por: Brentnall, Adam R., et al.
Publicado: (2019)

The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
por: Evans, D. Gareth, et al.
Publicado: (2021)

Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds
por: Wang, Chao, et al.
Publicado: (2018)

Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years
por: Brentnall, Adam R., et al.
Publicado: (2020)

A novel and fully automated mammographic texture analysis for risk prediction: results from two case-control studies
por: Wang, Chao, et al.
Publicado: (2017)

A comparison of five methods of measuring mammographic density: a case-control study
por: Astley, Susan M., et al.
Publicado: (2018)

Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort
por: Brentnall, Adam R., et al.
Publicado: (2015)

Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women
por: Evans, D. Gareth, et al.
Publicado: (2021)

Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography
por: Møller, Pål, et al.
Publicado: (2015)

The Relationship between Body Mass Index and Mammographic Density during a Premenopausal Weight Loss Intervention Study
por: Atakpa, Emma C., et al.
Publicado: (2021)

Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK
por: Evans, D. Gareth, et al.
Publicado: (2018)

Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester
por: Pegington, Mary, et al.
Publicado: (2023)

Psychological impact of providing women with personalised 10-year breast cancer risk estimates
por: French, David P., et al.
Publicado: (2018)

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
por: Gareth Evans, D., et al.
Publicado: (2023)

Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
por: Gareth Evans, D., et al.
Publicado: (2023)

What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)
por: French, David P., et al.
Publicado: (2020)

Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?
por: Leventea, Eleni, et al.
Publicado: (2021)

Breast cancer risk feedback to women in the UK NHS breast screening population
por: Evans, D Gareth R, et al.
Publicado: (2016)

Extended gene panel testing in lobular breast cancer
por: van Veen, Elke M., et al.
Publicado: (2021)

Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I
por: Warwick, Jane, et al.
Publicado: (2014)

Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom)
por: Renehan, Andrew G., et al.
Publicado: (2020)

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
por: Evans, D. Gareth, et al.
Publicado: (2021)

Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer
por: Woodward, Emma R., et al.
Publicado: (2021)

CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis
por: Behrouzi, Roya, et al.
Publicado: (2023)

PB.23. Breast density in previous screening mammograms of women with and without breast cancer
por: Sivagnanam, L, et al.
Publicado: (2014)

Local breast density at lesion sites in diagnostic and previous screening mammograms
por: Otsuka, M, et al.
Publicado: (2014)

Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
por: Howell, Sacha J., et al.
Publicado: (2020)

PB.22. Does mammographic compression force at breast screening influence the likelihood of subsequent screening attendance?
por: Meyer, J, et al.
Publicado: (2014)

Mammographic screening detects low-risk tumor biology breast cancers
por: Drukker, C. A., et al.
Publicado: (2014)

External validation of a mammographic texture marker for breast cancer risk in a case–control study
por: Wang, Chao, et al.
Publicado: (2020)

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials
por: Cuzick, Jack, et al.
Publicado: (2017)

Magnitude and attributed reasons for adult weight gain amongst women at increased risk of breast cancer
por: Pegington, Mary, et al.
Publicado: (2022)

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
por: Förnvik, Daniel, et al.
Publicado: (2019)

Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
por: Evans, D. Gareth, et al.
Publicado: (2019)

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
por: Bryant, Richard J., et al.
Publicado: (2020)

Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987–2020)
por: Howell, Anthony, et al.
Publicado: (2020)

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers
por: Obdeijn, Inge-Marie, et al.
Publicado: (2020)

Metaplastic breast cancer and BRCA1: first strong evidence of a link
por: Evans, D. Gareth R, et al.
Publicado: (2023)

Computer-assisted mammographic imaging
por: Boggis, Caroline RM, et al.
Publicado: (2000)

Risk factors. Introduction to Session 1
por: Howell, Anthony, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_mdcm6mg6qnerb909rbo7g2lc87